Publication & Citation Trends
Publications
48 total
Exploring the Myths and Actualities of Sex Trafficking: Empowering the Mental Health Community to Assist
Cited by 0
Semantic Scholar
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD PDF
Cited by 1,237
OpenAlex
Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies PDF
Cited by 64
OpenAlex
Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study PDF
Cited by 92
OpenAlex
Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study PDF
Cited by 29
OpenAlex
Shortness of Breath with Daily Activities questionnaire: validation and responder thresholds in patients with chronic obstructive pulmonary disease PDF
Cited by 25
OpenAlex
A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD
Cited by 65
OpenAlex
Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients
Cited by 54
OpenAlex
Research Topics
Chronic Obstructive Pulmonary Disease (COPD) Research
(35)
Asthma and respiratory diseases
(15)
Respiratory and Cough-Related Research
(15)
Delphi Technique in Research
(12)
Inhalation and Respiratory Drug Delivery
(7)
Affiliations
GlaxoSmithKline (United Kingdom)
GlaxoSmithKline (India)
GlaxoSmithKline (Germany)
GlaxoSmithKline (Netherlands)